BR0315516A - Derivados de acila de 5-(2-(4-(1,2-benzoisotiazol-3-il)-1-piperazinil)etil)-6-clo ro-1,3-dihidro-2h-indol-2-ona tendo atividade neuroléptica - Google Patents
Derivados de acila de 5-(2-(4-(1,2-benzoisotiazol-3-il)-1-piperazinil)etil)-6-clo ro-1,3-dihidro-2h-indol-2-ona tendo atividade neurolépticaInfo
- Publication number
- BR0315516A BR0315516A BR0315516-1A BR0315516A BR0315516A BR 0315516 A BR0315516 A BR 0315516A BR 0315516 A BR0315516 A BR 0315516A BR 0315516 A BR0315516 A BR 0315516A
- Authority
- BR
- Brazil
- Prior art keywords
- indol
- piperazinyl
- dihydro
- ethyl
- benzoisothiazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
"DERIVADOS DE ACILA DE 5-(2-(4-(1,2-BENZOISO-TIAZOL-3-IL)-1-PIPERAZINIL)ETIL)-6-CLO RO-1,3-DIHIDRO-2H-INDOL-2-ONA TENDO ATIVIDADE NEUROLéPTICA". A presente invenção refere-se a um processo para preparar derivados de acila como pró-drogas de 5-(2-(4-(1,2-benzoisotiazol-3-il)-1-piperazinil)etil)-6-cloro-1,3-dihidro-2 H-indol-2-ona e sais de adição de ácidos farmaceuticamente aceitáveis e métodos de utilização como um antipsicótico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42084302P | 2002-10-24 | 2002-10-24 | |
PCT/IB2003/004519 WO2004037819A1 (en) | 2002-10-24 | 2003-10-13 | Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0315516A true BR0315516A (pt) | 2005-08-23 |
Family
ID=32176638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0315516-1A BR0315516A (pt) | 2002-10-24 | 2003-10-13 | Derivados de acila de 5-(2-(4-(1,2-benzoisotiazol-3-il)-1-piperazinil)etil)-6-clo ro-1,3-dihidro-2h-indol-2-ona tendo atividade neuroléptica |
Country Status (25)
Country | Link |
---|---|
US (1) | US7019009B2 (pt) |
EP (1) | EP1556378B1 (pt) |
JP (1) | JP2006505578A (pt) |
KR (1) | KR100755625B1 (pt) |
CN (1) | CN100340557C (pt) |
AR (1) | AR041695A1 (pt) |
AT (1) | ATE383357T1 (pt) |
AU (1) | AU2003269331B2 (pt) |
BR (1) | BR0315516A (pt) |
CA (1) | CA2500485C (pt) |
CO (1) | CO5550441A2 (pt) |
CY (1) | CY1107300T1 (pt) |
DE (1) | DE60318602T2 (pt) |
DK (1) | DK1556378T3 (pt) |
ES (1) | ES2297200T3 (pt) |
HK (1) | HK1081185A1 (pt) |
MX (1) | MXPA05002734A (pt) |
NO (1) | NO20052475L (pt) |
NZ (1) | NZ566615A (pt) |
PL (1) | PL376721A1 (pt) |
PT (1) | PT1556378E (pt) |
RU (1) | RU2005112254A (pt) |
TW (1) | TW200418850A (pt) |
WO (1) | WO2004037819A1 (pt) |
ZA (1) | ZA200502109B (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2551346A1 (en) * | 2003-12-31 | 2005-07-21 | Warner-Lambert Company Llc | N-substituted piperidine and piperazine derivatives |
HRP20171415T4 (hr) | 2009-06-25 | 2023-03-03 | Alkermes Pharma Ireland Limited | Heterociklični spojevi za liječenje neuroloških i psiholoških poremećaja |
WO2010151711A1 (en) * | 2009-06-25 | 2010-12-29 | Alkermes, Inc. | Prodrugs of nh-acidic compounds |
WO2011163594A2 (en) * | 2010-06-24 | 2011-12-29 | Alkermes, Inc. | Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
EP2919788A4 (en) | 2012-11-14 | 2016-05-25 | Univ Johns Hopkins | METHODS AND COMPOSITIONS FOR THE TREATMENT OF SCHIZOPHRENIA |
CN112423754A (zh) | 2018-03-05 | 2021-02-26 | 奥克梅斯制药爱尔兰有限公司 | 阿立哌唑的给药策略 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5206366A (en) * | 1992-08-26 | 1993-04-27 | Pfizer Inc. | Process for preparing aryl piperazinyl-heterocyclic compounds |
US5312925A (en) * | 1992-09-01 | 1994-05-17 | Pfizer Inc. | Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride |
ES2210450T3 (es) * | 1996-02-13 | 2004-07-01 | Pfizer Inc. | Profarmacos de 5-(2-(4-(1,2-benzoisotiazol-3-il)-1-piperazinil)etil)-6-cloro-1,3-dihidro-2h-indol-2-ona. |
US6576656B1 (en) * | 1998-08-20 | 2003-06-10 | Sumitomo Pharmaceuticals Co., Ltd. | Oxindole derivative |
-
2003
- 2003-10-13 WO PCT/IB2003/004519 patent/WO2004037819A1/en active IP Right Grant
- 2003-10-13 NZ NZ566615A patent/NZ566615A/en not_active IP Right Cessation
- 2003-10-13 AU AU2003269331A patent/AU2003269331B2/en not_active Ceased
- 2003-10-13 KR KR1020057006938A patent/KR100755625B1/ko not_active IP Right Cessation
- 2003-10-13 AT AT03751112T patent/ATE383357T1/de not_active IP Right Cessation
- 2003-10-13 EP EP03751112A patent/EP1556378B1/en not_active Expired - Lifetime
- 2003-10-13 PL PL376721A patent/PL376721A1/pl not_active Application Discontinuation
- 2003-10-13 CN CNB2003801017404A patent/CN100340557C/zh not_active Expired - Fee Related
- 2003-10-13 DE DE60318602T patent/DE60318602T2/de not_active Expired - Fee Related
- 2003-10-13 PT PT03751112T patent/PT1556378E/pt unknown
- 2003-10-13 JP JP2004546256A patent/JP2006505578A/ja not_active Withdrawn
- 2003-10-13 CA CA2500485A patent/CA2500485C/en not_active Expired - Fee Related
- 2003-10-13 RU RU2005112254/04A patent/RU2005112254A/ru not_active Application Discontinuation
- 2003-10-13 MX MXPA05002734A patent/MXPA05002734A/es not_active Application Discontinuation
- 2003-10-13 ES ES03751112T patent/ES2297200T3/es not_active Expired - Lifetime
- 2003-10-13 BR BR0315516-1A patent/BR0315516A/pt not_active IP Right Cessation
- 2003-10-13 DK DK03751112T patent/DK1556378T3/da active
- 2003-10-21 US US10/689,773 patent/US7019009B2/en not_active Expired - Fee Related
- 2003-10-22 AR ARP030103846A patent/AR041695A1/es unknown
- 2003-10-23 TW TW092129426A patent/TW200418850A/zh unknown
-
2005
- 2005-03-14 ZA ZA200502109A patent/ZA200502109B/en unknown
- 2005-04-22 CO CO05038502A patent/CO5550441A2/es not_active Application Discontinuation
- 2005-05-23 NO NO20052475A patent/NO20052475L/no not_active Application Discontinuation
-
2006
- 2006-01-25 HK HK06101121A patent/HK1081185A1/xx not_active IP Right Cessation
-
2008
- 2008-03-12 CY CY20081100276T patent/CY1107300T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR20050065618A (ko) | 2005-06-29 |
TW200418850A (en) | 2004-10-01 |
KR100755625B1 (ko) | 2007-09-04 |
WO2004037819A1 (en) | 2004-05-06 |
JP2006505578A (ja) | 2006-02-16 |
NO20052475L (no) | 2005-07-25 |
CY1107300T1 (el) | 2012-11-21 |
HK1081185A1 (en) | 2006-05-12 |
MXPA05002734A (es) | 2005-05-23 |
ATE383357T1 (de) | 2008-01-15 |
US7019009B2 (en) | 2006-03-28 |
RU2005112254A (ru) | 2006-01-20 |
ZA200502109B (en) | 2006-05-31 |
NO20052475D0 (no) | 2005-05-23 |
NZ566615A (en) | 2009-08-28 |
DE60318602T2 (de) | 2009-01-15 |
PL376721A1 (pl) | 2006-01-09 |
CN1705663A (zh) | 2005-12-07 |
AR041695A1 (es) | 2005-05-26 |
AU2003269331A1 (en) | 2004-05-13 |
EP1556378B1 (en) | 2008-01-09 |
CA2500485A1 (en) | 2004-05-06 |
AU2003269331B2 (en) | 2010-02-18 |
CO5550441A2 (es) | 2005-08-31 |
DE60318602D1 (de) | 2008-02-21 |
US20040138232A1 (en) | 2004-07-15 |
PT1556378E (pt) | 2008-02-21 |
CA2500485C (en) | 2010-03-23 |
ES2297200T3 (es) | 2008-05-01 |
CN100340557C (zh) | 2007-10-03 |
DK1556378T3 (da) | 2008-03-17 |
EP1556378A1 (en) | 2005-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG170785A1 (en) | Benzothiazoles having histamine h3 receptor activity | |
EA200401136A1 (ru) | Предназначенная для перорального применения лекарственная форма для этилового эфира 3-[(2-{[4-(гексилоксикарбониламиноиминометил)фениламино]метил}-1-метил-1h-бензимидазол-5-карбонил)пиридин-2-иламино]пропионовой кислоты и его солей | |
HUP9902808A2 (hu) | 5-(2-(4-(1,2-Benzizotiazol-3-il)-1-piperazinil)-etil)-6-klór-1,3-dihidro-2-(1H)-indol-2-on (ziprazidon) mezilát-trihidrát sói, a vegyületek előállítása és dopamin D2 antagonistaként történő alkalmazása | |
DE60022504D1 (de) | Phenoxypropylamin-derivate | |
EA199800912A1 (ru) | Дигидратная соль мезилата 5-(2-(4-(1,2-бензизотиазол-3-ил)-1-пиперазинил)этил)-6-хлор-1,3-дигидро-2(1н)-индол-2-она, фармацевтическая композиция и способ лечения психотического расстройства | |
ATE260275T1 (de) | Substituierte thien-3-yl- sulfonylamino(thio)carbonyl-triazolin(thi)one | |
EA200971086A1 (ru) | Фармацевтические композиции и способ лечения шизофрении | |
BRPI0409465A (pt) | derivados de carboxamida como agentes antidiabéticos | |
NO20052475L (no) | Acylderivater av 5-(2-(4-(1,2 benzotiazol-3-yl)-1-piperazinyl)etyl)-6-klor-1,3-dihydro-2H-indol-2-on med neuroleptisk aktivitet. | |
BR0307894A (pt) | Heterocìclos tricìclicos fundidos úteis para o tratamento de distúrbios hiperproliferativos | |
BRPI0413223A (pt) | artigo do vestuário descartável | |
BRPI0406704A (pt) | Antagonistas de 5ht~7~ e agonistas inversos | |
DE60002583D1 (de) | Benzofurylpiperazine als serotonin-agonisten | |
DK0790236T3 (da) | Prolægemidler af 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chlor-1,3-dihydro-2H-indol-2-on | |
EA200970044A1 (ru) | Производные пирролидина, обладающие активностью в отношении транспортера glyt1 | |
UY26568A1 (es) | Nuevos derivados de amidas heterocíclicas | |
BR0307490A (pt) | Derivado de piperidina e composição farmacêutica que compreende o mesmo como ingrediente ativo | |
EA200400877A1 (ru) | 2'-гало-3',5'-диалкоксифен-1'-илимино-2-имидазолидиновые производные и их применение для лечения недержания мочи | |
BR0315762A (pt) | Utilização de derivados de ácidos piperazino-sulfónicos como antagonistas ccr1 para o tratamento de fibrose, doença de alzheimer e outras doenças | |
PE20011329A1 (es) | S-metil-dihidro-ziprasidona para el tratamiento de trastornos psiquiatricos y oculares | |
PT1330246E (pt) | Utilizacao de derivados do acido hidroxieicosatetraenoico em cirurgia intraocular | |
EA200900725A1 (ru) | Полиморфы гидробромида 5-{2-[4-(1,2-бензоизотиазол-3-ил)-1-пиперазинил]этил}-6-хлор-1,3-дигидро-2н-индол-2-она и способы их получения | |
DK1421086T3 (da) | 2-(Aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl-derivater med antipsykotisk aktivitet | |
BR0211340A (pt) | Derivados de 2-(aminometil)-tetraidro-9-oxa-1,3-diaza-ciclopenta[a ]naftalenila com atividade antipsicótica | |
WO2004035534A3 (de) | Neue verbindungen mit dopaminerger und/oder serotoninerger aktivität |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08L | Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette] |
Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 9A E 10A ANUIDADES. |
|
B08I | Publication cancelled [chapter 8.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2256 DE 01/04/2014 POR TER SIDO INDEVIDA. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 9A, 10A, 11A, 12A, 13A, 14A, 15A, 16A E 17A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |